| 000 | 01620 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250513184304.0 | ||
| 264 | 0 | _c19990712 | |
| 008 | 199907s 0 0 eng d | ||
| 022 | _a1524-4539 | ||
| 024 | 7 |
_a10.1161/01.cir.99.23.3009 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aHeymes, C | |
| 245 | 0 | 0 |
_aEndomyocardial nitric oxide synthase and left ventricular preload reserve in dilated cardiomyopathy. _h[electronic resource] |
| 260 |
_bCirculation _cJun 1999 |
||
| 300 |
_a3009-16 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aCardiac Catheterization |
| 650 | 0 | 4 |
_aCardiomyopathy, Dilated _xcomplications |
| 650 | 0 | 4 | _aCoronary Angiography |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aGene Expression Regulation, Enzymologic |
| 650 | 0 | 4 |
_aHeart Failure _xenzymology |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aMyocardium _xenzymology |
| 650 | 0 | 4 |
_aNitric Oxide Synthase _xgenetics |
| 650 | 0 | 4 | _aNitric Oxide Synthase Type II |
| 650 | 0 | 4 | _aNitric Oxide Synthase Type III |
| 650 | 0 | 4 | _aRegression Analysis |
| 650 | 0 | 4 | _aReverse Transcriptase Polymerase Chain Reaction |
| 650 | 0 | 4 |
_aStroke Volume _xdrug effects |
| 650 | 0 | 4 |
_aSubstance P _xpharmacology |
| 650 | 0 | 4 |
_aVentricular Function, Left _xdrug effects |
| 700 | 1 | _aVanderheyden, M | |
| 700 | 1 | _aBronzwaer, J G | |
| 700 | 1 | _aShah, A M | |
| 700 | 1 | _aPaulus, W J | |
| 773 | 0 |
_tCirculation _gvol. 99 _gno. 23 _gp. 3009-16 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1161/01.cir.99.23.3009 _zAvailable from publisher's website |
| 999 |
_c10326650 _d10326650 |
||